相关实验视频

Updated: May 23, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

mRNA疫苗:基于miRNA的受控生物分布和有针对性的辅助剂

Byron Brook¹, Morgan Goetz¹, Valerie Duval²

¹Precision Vaccines Program, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.

Trends in immunology

|April 23, 2025

概括

电离性脂质纳米颗粒 (mRNA-LNP) 启用了COVID-19的mRNA疫苗. 未来的mRNA疫苗可以通过优化LNP输送,转录控制和辅助来提高效率和安全性来改进.

科学领域:

生物技术是生物技术.
疫苗开发疫苗开发
纳米医学是一种纳米医学.

背景情况:

电离性脂质纳米颗粒 (mRNA-LNP) 对于mRNA疫苗的输送至关重要,使BNT162b2和mRNA-1273.3等COVID-19疫苗的成功成为可能.
mRNA疫苗的临床转化突显了先进的输送系统的重要性.

研究的目的:

为了探索mRNA疫苗的合理改进.
通过传递系统修改和精确准,专注于提高mRNA疫苗性能的策略.

主要方法:

讨论控制的mRNA-LNP生物分布的LNP修改.
研究编码转录生物分布的基于微RNA (miRNA) 的控制.
探索精确辅助策略. 探索精确辅助策略.

主要成果:

摘要不包含具体的结果,但概述了未来研究和开发的领域.
专注于LNP修改,基于miRNA的转录控制和精确辅助.

结论:

优化LNP特性和结合基于miRNA和辅助剂的策略可以导致下一代mRNA疫苗.
对这些领域的进一步研究有望提高疫苗的有效性,安全性和有针对性的输送.

关键词:

辅助剂辅助剂是一种辅助剂.生物分销生物分销在mRNA疫苗的使用中.这是一个微型RNA.

更多相关视频

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

MicroRNA-based Regulation of Picornavirus Tropism

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...